Category Archives: News

A-LIGN announces strategic investment from Hg to accelerate its global expansion

HG Capital

Partnership with Hg will accelerate A-LIGN’s growth trajectory and support its mission to become the global cyber compliance services champion.

TAMPA, FLORIDA, July 8th: A-LIGN, a leading provider of technology-enabled cybersecurity compliance services, today announces that it has secured a significant strategic investment from Hg, a leading investor in European and transatlantic software and services businesses. Hg will acquire a majority stake in the company from Warburg Pincus.

The investment comes as organizations face a surge in cyber-attacks, with AI-powered threats making compliance and security more critical and complex than ever before. This has increased the demand for sophisticated compliance partners to navigate this environment and provide assurance to stakeholders.

Headquartered in Tampa, Florida, A-LIGN’s cybersecurity compliance audits and related assessments allow organizations to provide assurances to their customers that sensitive data is protected, and that mission-critical operations are conducted with integrity.

Since its founding in 2009, A-LIGN has established itself as a category leader in cybersecurity compliance services, serving over 5,700 clients with audits and assessments including SOC 2, ISO, HITRUST, FedRAMP, CMMC and PCI standards.

A-LIGN’s customer-first approach and extensive use of technology has enabled the firm to deliver over 50% compounded annual growth over the past 15 years. A-LIGN’s delivery model combines deep domain expertise with proprietary technology, to deliver superior audit quality, while driving operational efficiency for its customers.

The partnership with Hg will support A-LIGN’s ambitious growth plans, leveraging Hg’s extensive network to accelerate its global expansion, and building on Hg’s commitment and expertise in data and AI to drive significant value for A-LIGN’s customers.

Scott Price, CEO of A-LIGN, commented: “This new partnership comes at the perfect time as we enter our next phase of growth. Hg’s deep expertise and track record in scaling tech-enabled services businesses globally, combined with world-class operational resources, makes them the ideal partner to help us provide the best possible services to our customers. I’d also like to thank Warburg Pincus and FTV Capital for their support over the last few years, in helping us reach this milestone.”

Hector Guinness and Joris van Gool, Partners at Hg: “Scott and his world-class team have built an exceptional and truly client-centric business. We have been particularly impressed by their unwavering commitment to quality, while leveraging proprietary technology to drive efficiency for their customers. This combination has created a sustainable source of competitive differentiation that we believe can extend A-LIGN’s growth in new regions, adjacent service lines, and new customer groups.”

William Holmes, Principal at Hg, added: “A-LIGN has all the hallmarks of what Hg looks for in tech-enabled services investments, and we are excited to support Scott and his world-class team to become the global champion in cyber compliance services.”

Brian Chang, Managing Director at Warburg Pincus, said: “It has been a privilege to support Scott and the talented team at A-LIGN through an exceptional period of transformative growth, partnering closely with them to expand the company’s service offerings and grow its customer base. A-LIGN is a strong example of our firm’s focus on accelerating the success of innovative market leaders in cybersecurity and compliance, especially as the number of cyber-attacks continue to rise and compliance and security needs become more complex. We wish Scott and the A-LIGN team the best in their next chapter and look forward to the company’s continued success.”

Jefferies LLC served as lead financial advisor and Guggenheim Securities, LLC served as financial advisor to A-LIGN and Warburg Pincus. Cleary Gottlieb Steen & Hamilton LLP served as legal counsel for A-LIGN and Warburg Pincus. Harris Williams served as financial advisor to Hg, with Latham & Watkins serving as Hg’s legal counsel.

For further information, please contact:

A-LIGN
Press inquiries, press@a-lign.com

Hg
Tom Eckersley, tom.eckersley@hgcapital.com
Sam Ferris, sam.ferris@hgcapital.com

Warburg Pincus
Kerrie Cohen, kerrie.cohen@warburgpincus.com

About A-LIGN
A-LIGN is the leading cybersecurity compliance partner, trusted by over 5,700 organizations worldwide to navigate the complexities of compliance, audit, and risk.

With a tech-enabled delivery model and deep domain expertise, A-LIGN has completed more than 31,000 audits. It is the #1 issuer of SOC 2 reports and a top three FedRAMP assessor. Founded in 2009, A-LIGN delivers high-quality, efficient audits across frameworks including SOC 2, ISO 27001, FedRAMP, CMMC, ISO 42001, PCI, and HITRUST. To learn more, visit: https://www.a-lign.com.

About Hg
Hg is a leading investor in European and transatlantic software and services businesses. We help to build sector-leading enterprises that supply critical software applications or workflow services to deliver intelligent automation for their customers.

We take an active approach to value creation, combining deep end-market knowledge with world class operational resources to provide compelling support to entrepreneurial leaders looking to scale enduring businesses.

With a vast European network and strong presence across North America, Hg has more than $85 billion in assets under management and more than 400 employees. Our portfolio spans more than 50 companies worth over $160 billion in aggregate enterprise value, employing more than 126,000 people and consistently growing revenues at more than 20% annually.

About Warburg Pincus
Warburg Pincus LLC is the pioneer of private equity global growth investing. A private partnership since 1966, the firm has the flexibility and experience to focus on helping investors and management teams achieve enduring success across market cycles.

Today, the firm has more than $87 billion in assets under management, and more than 220 companies in their active portfolio, diversified across stages, sectors, and geographies. Warburg Pincus has invested in more than 1,000 companies across its private equity, real estate, and capital solutions strategies.

The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, São Paulo, Shanghai, and Singapore. For more information, please visit www.warburgpincus.com or follow us on LinkedIn.

Categories: News

Tags:

TEAM Technologies, an Arlington Capital Partners Portfolio Company, Expands Medical Device Manufacturing Capabilities with Acquisition of Duke Empirical, Inc.

TEAM Technologies, an Arlington Capital Partners Portfolio Company, Expands Medical Device Manufacturing Capabilities with Acquisition of Duke Empirical, Inc.

Washington, D.C. and Knoxville, TN – July 7, 2025 – Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced that its portfolio company TEAM Technologies (“TEAM Tech”), a leading end-to-end outsourced manufacturer of mission-critical medical devices, has acquired another leader in the sector, Duke Empirical, Inc (“Duke”). Based in Morgan Hill, CA., Duke is a leading designer, developer and manufacturer of advanced medical devices for interventional cardiovascular applications. Duke specializes in the design and manufacture of innovative catheters and minimally invasive delivery systems.

TEAM Tech works with blue-chip healthcare customers and medical device OEMs to provide end-to-end outsourced design and manufacturing services for critical medical devices, enabling customers to streamline their supply chains and reduce delivery lead times. With synergistic production capabilities and customer bases, the acquisition of Duke will further complement TEAM’s turnkey offering for healthcare and MedTech OEMs, enabling accelerated manufacturing at scale for complex Class II / III medical devices and delivery systems.

“Our investment in TEAM Tech reflects Arlington’s focus on building businesses that deliver mission critical solutions in complex, regulated end markets. The addition of Duke expands TEAM Tech’s ability to serve leading healthcare and MedTech OEMs in the fastest growing segments of the medical device market, while enhancing its capabilities to develop and manufacture highly advanced devices that support the delivery of life saving medical procedures,” said Matt Altman, a Managing Partner at Arlington Capital Partners.

“When we began our partnership with Arlington, we knew we had an opportunity to accelerate our growth and expand our offerings to best serve our clients,” said Marshall White, President and CEO of TEAM Tech. “Duke adds complementary capabilities and greater capacity to our already robust portfolio of full-service medical device manufacturing solutions, and will enable us to provide a greater breadth of complete solutions for our customer partners, who are doing critical, lifesaving work across the healthcare field.”

“The acquisition of Duke enhances TEAM Tech’s capabilities by furthering its expertise in designing and manufacturing advanced interventional cardiovascular products as well as polymer extrusion,” said Gordon Auduong, Managing Director at Arlington Capital Partners. “We are excited to partner with the exceptional team at Duke to deliver TEAM Tech’s entire portfolio of capabilities to further support our customers’ growth.”

Arlington has an extensive track record of building leading companies in highly regulated industries that are critical to the USA’s healthcare infrastructure, government systems and national security. Within healthcare, Arlington focuses on working with businesses that save lives, improve the delivery of products and services and reduce costs for patients and providers. Other notable recent healthcare sector investments the firm has made include Riverpoint Medical, Millstone Medical Outsourcing, Grand River Aseptic Manufacturing, Everest Clinical Research, Afton Scientific and AVS Bio.

Houlihan Lokey served as financial advisor and Goodwin Procter LLP served as legal advisor to TEAM Tech and Arlington Capital Partners.

 

About Arlington Capital Partners

Arlington Capital Partners is a Washington, D.C.-area private investment firm specializing in government-regulated industries. The firm partners with founders and management teams to build strategically important businesses in the healthcare, government services and technology, and aerospace and defense sectors. Since its inception in 1999, Arlington has invested in over 175 companies and is currently investing out of its $3.8 billion Fund VI. For more information, visit Arlington’s website at www.arlingtoncap.com and follow Arlington on LinkedIn.

 

About TEAM Technologies

Headquartered in Knoxville, TN, with facilities throughout the United States and international facilities in Mexico and Singapore, TEAM Technologies is a specialized end-to-end outsourced manufacturer of mission-critical, single-use medical devices. The company has an extensive array of advanced and vertically integrated manufacturing solutions servicing top medical device and pharmaceutical OEMs. With its deep industry experience and reputation for the highest quality standards, TEAM Technologies leverages seamless, turnkey processes and innovation to dramatically simplify and improve its customers’ supply chains. For more information, visit teamtech.com.

 

About Duke Empirical, Inc.

Headquartered in Morgan Hill, CA, Duke Empirical is a leading developer and manufacturer of innovative medical devices focused on advanced catheters and minimally invasive delivery systems. The company specializes in medical device design and development, precision custom extrusion, high performance catheter manufacturing, medical device component assembly, and finished goods assembly and packaging. For more information, visit dukeempirical.com.

 

Contacts

Media Contact

 

Ryan FitzGibbon

Pro-arlington@prosek.com

Categories: News

Tags:

Tikehau Capital raises €1 billion to support Egis’ next phase of growth, with backing from an Apollo S3 / ADIA consortium and Neuberger Berman as co-lead investors

Tikehau

Tikehau Capital, the global alternative asset manager, announces a capital raise for its portfolio company Egis, reaffirming its long-term commitment to supporting the company’s international expansion. This transaction marks the launch of Tikehau Capital’s first private equity continuation fund dedicated to Egis, with a size exceeding €1 billion. The fund aims to support Egis’ growth trajectory and accelerate its global development, particularly through strategic acquisitions. This investment is backed by the second vintage of Tikehau Capital’s flagship private equity decarbonisation strategy, as well as a leading group of investors including as co-lead investors: – – A consortium comprising of Apollo S3 and a wholly owned subsidiary of the Abu Dhabi Investment Authority (“ADIA”) and Neuberger Berman (managed funds on behalf of clients).

This transaction marks the fourth investment made through the second vintage of Tikehau Capital’s private equity strategy dedicated to decarbonisation. With this transaction, the second vintage has surpassed €2 billion in capital raised, just one year after its first closing, reaching a size 1.5 times larger than its predecessor.

Egis is a global leader in architecture, consulting, engineering, construction and mobility services. The company designs, develops and operates smart infrastructure and buildings that address climate change challenges while fostering more balanced, sustainable and resilient development.

Tikehau Capital initially acquired from Caisse des Dépôts et Consignations (CDC) a control position in Egis in January 2022 through the first vintage of its flagship private equity decarbonisation strategy to support Egis’ objectives of executing strategic acquisitions to expand internationally. Egis exceeded the growth targets it set out in 2022 several years ahead of plan; and since then it has more than doubled its EBITDA and exceeded its revenue targets, with revenue surpassing €2.2 billion in 2024.

The capital raise secured via the continuation fund managed by Tikehau Capital should enable Egis to continue this journey and will support its next growth phase, in which the company aims to double its size by 2028 and further solidify its position as a global leader in the decarbonisation of transport, cities and energy. In addition, as part of this transaction, the continuation vehicle also benefits from additional subscription commitments to support future capital increases, supporting Egis with the necessary financial resources to pursue its successful buy-and-build-strategy. CDC remains a key shareholder to support Egis’ development.

Tikehau Capital’s decarbonization strategy focuses on investing in companies at the forefront of global electrification, resource and energy efficiency, low-carbon solutions and climate adaptation. Through this investment strategy, Tikehau Capital continues to support businesses that play a critical role in meeting the growing global energy demand while reducing the carbon footprint of the economy and enhancing its resilience. Mathieu Badjeck and Pierre Abadie, Co-Heads of Tikehau Capital’s Private Equity Decarbonisation Strategy, and Emmanuel Laillier, Private Equity Chief Investment Officer at Tikehau Capital, declared: “Reinvesting in Egis through our second vintage is a natural step in our mission to back transformative companies driving the decarbonisation of the economy. This next chapter of Egis’ growth promises to be even more ambitious, and we are excited to build on its strong momentum, further scaling its impact worldwide. Over the past three years, Egis’ management has demonstrated outstanding leadership, successfully driving rapid expansion, strategic acquisitions and operational excellence. We are thrilled to continue this partnership as Egis seeks to strengthen its position as a global leader in sustainable infrastructure and low-carbon solutions.” Laurent Germain, CEO of Egis, and Olivier Gouirand, CFO of Egis, said: “We are grateful for the continued support of our shareholder, Tikehau Capital. Since 2022, our journey has demonstrated the full potential of a strong collaboration between Egis’ management and the Tikehau Capital private equity team, helping to transform Egis and strengthen its position among industry leaders. Tikehau Capital’s confidence has enabled us to pursue our ambitious strategic plan, “Impact the Future”, with determination – aiming to join the top 10 construction engineering companies and tackle the challenge of decarbonisation. We welcome Apollo S3, ADIA and Neuberger Berman and appreciate their trust. This transaction reaffirms the relevance of our strategy and our ability to achieve our ambitions together with our 20,500 employees. With future investment commitments, Egis will be able to strengthen its capital base and pursue new strategic M&A opportunities, particularly in North America, where we aim to build a platform that matches the scale of the market.”

ABOUT TIKEHAU CAPITAL Tikehau Capital is a global alternative asset management Group with €50.6 billion of assets under management (at 31 March 2025). Tikehau Capital has developed a wide range of expertise across four asset classes (credit, real assets, private equity and capital markets strategies) as well as multi asset and special opportunities strategies. Tikehau Capital is a founder-led team with a differentiated business model, a strong balance sheet, proprietary global deal flow and a track record of backing high quality companies and executives. Deeply rooted in the real economy, Tikehau Capital provides bespoke and innovative alternative financing solutions to companies it invests in and seeks to create long-term value for its investors, while generating positive impacts on society. Leveraging its strong equity base (€3.2 billion of shareholders’ equity at 31 December 2024), the Group invests its own capital alongside its investor-clients within each of its strategies. Controlled by its managers alongside leading institutional partners, Tikehau Capital is guided by a strong entrepreneurial spirit and DNA, shared by its 750 employees (at 31 March 2025) across its 17 offices in Europe, the Middle East, Asia and North America. Tikehau Capital is listed in compartment A of the regulated Euronext Paris market (ISIN code: FR0013230612; Ticker: TKO.FP). For more information, please visit: www.tikehaucapital.com.

PRESS CONTACTS: Tikehau Capital: Valérie Sueur – +33 1 40 06 39 30 UK – Prosek Partners: Philip Walters – +44 (0)7773331589 USA – Prosek Partners: Trevor Gibbons – +1 646 818 9238 press@tikehaucapital.com Egis : MAYRAND Isabelle – isabelle.mayrand@egis-group.com – +33 6 17 10 29 70 SHAREHOLDER AND INVESTOR CONTACTS: Louis Igonet – +33 1 40 06 11 11 Théodora Xu – +33 1 40 06 18 56 Julie Tomasi – +33 1 40 06 58 44 shareholders@tikehaucapital.com ABOUT EGIS Egis is a leading global architectural, consulting, construction engineering, operations and mobility services firm. We create and operate intelligent infrastructures and buildings that respond to the climate emergency and contribute to more balanced, sustainable and resilient territorial development. Operating in 100 countries, Egis puts the expertise of its 20,500 employees at the service of its clients and develops cutting-edge innovations accessible to all projects. Through its wide range of activities, Egis is a key player in the collective organisation of society and the living environment of citizens all over the world.

DISCLAIMER The strategy mentioned in this press release is reserved for professional investors and is managed by Tikehau Investment Management SAS, a portfolio management company approved by the AMF since 19/01/ 2007 under the number GP-07000006. Non-contractual document intended exclusively for journalists and media professionals. The information is provided for the sole purpose of enabling them to have an overview of the transactions, whatever the use they make of it, which is exclusively a matter of their editorial independence, for which Tikehau Capital declines all responsibility. This document does not constitute an offer to sell securities or investment advisory services. This document contains only general information and is not intended to represent general or specific investment advice. Past performance is not a reliable indicator of future results and targets are not guaranteed. Certain statements and forecasted data are based on current forecasts, prevailing market and economic conditions, estimates, projections and opinions of Tikehau Capital and/or its affiliates. Owing to various risks and uncertainties actual results may differ materially from those reflected or expected in such forward-looking statements or in any of the case studies or forecasts. Tikehau Capital accepts no liability, direct or indirect, arising from the information contained in this document. Tikehau Capital shall not be liable for any decision taken on the basis of any information contained in this document. All references to Tikehau Capital’s advisory activities in the US or with respect to US persons relate to Tikehau Capital North America.

Categories: News

Tags:

Blackstone Real Estate to Acquire Sunseeker Resort Charlotte Harbor from Allegiant Travel Company for $200 Million

Blackstone

New York & Las Vegas – Blackstone (NYSE: BX) and Allegiant Travel Company (NASDAQ: ALGT) today announced that funds affiliated with Blackstone Real Estate have agreed to acquire Sunseeker Resort Charlotte Harbor from Allegiant for $200 million.

With 785 rooms spanning 22 waterfront acres on the Gulf Coast of Florida, Sunseeker Resort Charlotte Harbor is a brand-new resort with extensive core amenities, including multiple food and beverage concepts, two pools, a spa, a fitness center, a rooftop adult pool and bar, a championship golf course and more than 60,000 square feet of combined indoor meeting space.

Scott Trebilco, Senior Managing Director at Blackstone Real Estate, said: “The acquisition of this brand new, highly-amenitized resort demonstrates our strong conviction in hospitality and travel and the continued growth in group-oriented destinations. Allegiant has built a fantastic property and we look forward to bringing our extensive experience with large scale resorts to Sunseeker.”

“Blackstone’s extensive hospitality holdings and their execution capabilities make them the ideal counterparty for this transaction and also to help realize the full potential of Sunseeker Resort,” said Gregory C. Anderson, CEO at Allegiant Travel Company. “Furthermore, it supports Allegiant’s strategy centered around the airline and we plan to use the proceeds from the sale to repay debt and strengthen our balance sheet.”

Barclays served as financial advisor to Allegiant on this transaction.

The transaction is expected to close in the third quarter of 2025, subject to satisfying customary conditions.

About Blackstone Real Estate
Blackstone is a global leader in real estate investing. Blackstone’s real estate business was founded in 1991 and has US $320 billion of investor capital under management. Blackstone is the largest owner of commercial real estate globally, owning and operating assets across every major geography and sector, including logistics, data centers, residential, office and hospitality. Our opportunistic funds seek to acquire undermanaged, well-located assets across the world. Blackstone’s Core+ business invests in substantially stabilized real estate assets globally, through both institutional strategies and strategies tailored for income-focused individual investors including Blackstone Real Estate Income Trust, Inc. (BREIT). Blackstone Real Estate also operates one of the leading global real estate debt businesses, providing comprehensive financing solutions across the capital structure and risk spectrum, including management of Blackstone Mortgage Trust (NYSE: BXMT).

Allegiant – Together We FlyTM
Las Vegas-based Allegiant (NASDAQ: ALGT) is an integrated travel company with an airline at its heart, focused on connecting customers with the people, places and experiences that matter most. Since 1999, Allegiant Air has linked travelers in small-to-medium cities to world-class vacation destinations with all-nonstop flights and industry-low average fares. Today, Allegiant serves communities across the nation, with base airfares less than half the cost of the average domestic roundtrip ticket. For more information, visit us at Allegiant.com. Media information, including photos, is available at http://gofly.us/iiFa303wrtF.

Contacts
Jeffrey Kauth
212-583-5395
Jeffrey.Kauth@blackstone.com

Allegiant
702-800-2020
mediarelations@allegiantair.com

Categories: News

Tags:

Gilde Healthcare’s private equity fund combines Artinis and NIRx into a world-leading neuroimaging group

GIlde Healthcare

Gilde Healthcare today announces the combined private equity investments in Artinis Medical Systems (Netherlands) and NIRx Medical Technologies (Germany/United States), both pioneers in functional Near-Infrared Spectroscopy (fNIRS) solutions. This dual transaction brings together two highly complementary companies, establishing a new global leader in fNIRS.

Advancing fNIRS technology
Functional Near-Infrared Spectroscopy is a differentiated neuroimaging technology that offers unique advantages over traditional brain imaging methods such as fMRI and EEG. The technology offers scientists a new perspective on understanding the functions of the human brain, enabling, high-impact, neuroscience research worldwide. With its strong scientific foundation in basic research, fNIRS is increasingly adopted in applied research environments, unlocking its potential in therapeutic areas such as neurodegenerative diseases, mental health, stroke rehabilitation and developmental neuroscience.

Joining forces for innovation
Artinis and NIRx, both recognized as market leaders with superior technology and support, will continue to operate from their current locations and under their existing brand names. The founders and current management teams of both companies remain actively involved. The newly formed group will leverage its complementary product offerings, shared expertise, integrated R&D, and increased scale to accelerate innovation and commercial growth.

The shared vision is to develop the newly formed group in the go-to platform for neuroimaging- and related research tools while driving innovation across (multi-)modalities. The new platform aims to enhance the adoption of fNIRS in applied neuroscience by setting industry standards, and by making the technology more accessible to academic researchers globally. Apart from organic growth, the group will pursue additional add-on acquisitions in line with this vision.

Gilde’s entrepreneurial investment strategy to drive better care at lower cost
This transaction exemplifies Gilde Healthcare’s entrepreneurial investment strategy, which focuses on partnering with founders and managers to accelerate growth and develop organizations in attractive healthcare niches.  The investment via two parallel transactions was executed in a proprietary setting, leveraging Gilde’s own developed investment thesis, broad network and deep expertise in the research tools sector.

By combining Artinis and NIRx, Gilde Healthcare enables the formation of a global market leader with the ability to fuel ground-breaking neuroscience research that addresses the growing complexity and prevalence of brain-related conditions. This ultimately contributes to better care and lower cost for the healthcare system.

Willy Colier, co-founder and CEO of Artinis, commented: “Roeland, my co-founder, and I are proud of Artinis’ journey over the past 24 years. We have built a company known for its great products, fantastic people, and satisfied customers. Joining forces with NIRx is an exciting step that will enhance the value we provide to both our current and future customers. We look forward to this new phase as we leverage our combined scale and expertise, benefiting from the support of Gilde Healthcare. “

Patrick Britz, CEO of NIRx, commented: “Constant innovation has made functional near-infrared spectroscopy a rapidly growing and highly productive solution for neuroscience. Now, with the strong support of Gilde Healthcare, two highly skilled teams, NIRx and Artinis, are joining forces to accelerate these advancements. I am genuinely thrilled about the possibilities this partnership unlocks, fNIRS is just at its beginning.”

Boyd Rutten, Investment Director at Gilde Healthcare, commented: “These parallel transactions are an excellent example of our entrepreneurial investment strategy. By bringing both companies together, we are creating a platform that will lead innovation and makes brain imaging tools more accessible to researchers globally. We want to thank the founders of Artinis and NIRx for their trust and express our excitement about working together going forward.”         

Completion of the transaction is subject to regulatory approval.

About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medtech and therapeutics, based in Europe and North America. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. For more information, visit the company’s website at www.gildehealthcare.com.

Categories: News

Tags:

Soltech Energy acquires Sesol, gains Nordic Capital as largest shareholder and presents preliminary figures for April and May

Nordic Capital

As part of the ongoing consolidation of the solar energy industry, Soltech Energy Sweden AB (publ) (“Soltech” or the “Group”) has signed an agreement to acquire 100 percent of the shares in the solar energy company Sesol Group AB (“Sesol”) from Nordic Capital. The purchase price will be paid with newly issued shares in Soltech, which means that Nordic Capital will own approximately 30 percent of the shares in Soltech after the transaction and Nordic Capital will thus become the largest shareholder in Soltech. The acquisition is subject to regulatory approvals and resolutions by an Extraordinary General Meeting in Soltech.

For the full press release, see  https://soltechenergy.com/en/mfn_news/soltech-energy-acquires-sesol-gains-nordic-capital-as-largest-shareholder-and-presents-preliminary-figures-for-april-and-may/

Categories: News

Tags:

Altor invests in IMBOX in partnership with the founder René Marker and the Grundtvig family

Altor Fund VI (“Altor”) has signed an agreement to acquire a majority stake in IMBOX Protection A/S (“IMBOX”) and enter into a partnership with the founder, René Marker, and the Grundtvig family. Altor will support the founder and the company on its continued international growth journey. The founder and the Grundtvig family will remain significant shareholders and continue supporting the development of IMBOX. René Marker will continue in his role as CEO.

Founded by René Marker in 2009 in Denmark, IMBOX is a niche engineering company and a first mover in providing automated footwear protection machines through an equipment-as-a- service model to a wide range of retail customers across both physical stores and e-commerce channels. The company is headquartered in Skødstrup, Denmark where it designs and develops the globally patented technology. IMBOX is currently present in 37 countries and has an installed base of ~9,700 machines in ~8,900 stores. Across its installed base, IMBOX sells one treatment per second, and generates around DKK 1 billion of revenue for retailers.

“We are really excited to hit the ground running with Altor as a partner. We will benefit from their long expertise of helping companies scale internationally and add relevant experience for the next phase of our joint growth journey. Together, we will ensure that more end-users and stores will have access to our offering” says René Marker, Founder and CEO of IMBOX.

Henrik Grundtvig from the Grundtvig family continued, “Early on, we had the opportunity to help bring a Danish innovation to life. Since then, we have built a competitive o`ering with globally patented technologies. We are excited to continue the partnership with René and Altor while still only seeing the beginning of the IMBOX journey”.

“IMBOX is an excellent example of a strong and proven technology built to meet the needs of its industry and customers. We are really impressed by what René and the Grundtvig family have built over the years and look forward to being part of continued growth journey.” says Jens Browaldh, Partner at Altor. “As IMBOX embarks on its next chapter, the company will continue to benefit from René’s leadership and his team’s deep technical and industry expertise, now complemented by Altor’s experience to support accelerated growth. Our ambition is to at least triple the installed base over the next 3 to 5 years,” says Karl Svenningson, Principal at Altor.

Parties have agreed not to disclose the financial details.

About Altor

Since inception, the family of Altor funds has raised more than EUR 12 billion in total commitments. The funds have invested in more than 100 companies. The investments have been made in medium-sized companies predominantly in Nordic and DACH with the aim to create value through growth initiatives and operational improvements. Among current and past investments are Eleda, FLSmidth, Toteme, Silo AI, Marshall and Helly Hansen.

About Imbox

IMBOX develops easy-to-use premium machines for automated footwear protection at the point-of-sale. The product portfolio currently includes two machines; the IMBOX Original and IMBOX Flagship, which has won a Red Dot Design Award. The solution is provided through a hardware-as-a-service revenue-sharing model to omnichannel footwear and sports retailers, department stores and e-commerce shops. IMBOX is headquartered in Skødstrup, Denmark.

Press contact

Karin Åström

Head of Communications

karin.astrom@altor.com

+46 707 64 86 59

Categories: News

Tags:

CapMan Real Estate invests SEK 692 million in 205-unit multifamily housing development in Stockholm

Capman

CapMan Real Estate, through its third value-add fund CapMan Nordic Real Estate III (“CMNRE III”, the “Fund”), has acquired a residential development project comprising 205 rental units in Jakobsberg, Järfälla from JM. The project is expected to be completed in Q4 2027.

Located in a highly attractive micro-location with excellent access to public transportation, the site offers commuting time of under 25 minutes to central Stockholm. The area benefits from strong tenant demand and a limited supply of rental housing. Designed to meet high sustainability standards, the project will feature BREEAM certification, a minimum EPC rating of B, solar panels, EV charging stations, and aims for EU Taxonomy alignment. Tenants will benefit from a range of mobility solutions, including access to carpool, to support sustainable commuting.

“We are pleased to grow our residential portfolio in Greater Stockholm and act on compelling opportunities in the current market. With strong fundamentals and structural supply-demand imbalances, the residential sector remains a high-conviction theme for us. This project is designed to meet the growing need for high-quality, middle-income rental housing in one of Europe’s fastest-growing metropolitan areas,” says Pontus Danielsson, Investment Manager at CapMan Real Estate.

“This acquisition is fully aligned with our strategy of investing in sustainable, well-located residential assets across key Nordic growth regions. With strong local market knowledge and a robust deal pipeline, we are well positioned to continue scaling our residential platform,” adds Marcus Lotzman, Head of Transactions, Sweden at CapMan Real Estate.

The transaction is structured as a forward purchase, with closing expected upon project completion in Q4 2027. It marks the 22nd investment made by CMNRE III.

CapMan Real Estate manages approximately €5.5 billion in real estate assets, with a team of over 80 professionals based in Helsinki, Stockholm, Copenhagen, Oslo and London.

For further information, please contact:

Marcus Lotzman, Head of Transactions, Sweden, +46 70 680 60 81

Pontus Danielsson, Investment Manager, +46 70 385 58 00

About CapMan

CapMan is a leading Nordic private asset expert with an active approach to value creation and €6.4 billion in assets under management. As one of the private equity pioneers in the Nordics we have developed hundreds of companies and assets creating significant value for over three decades. Our objective is to provide attractive returns and innovative solutions to investors by enabling change across our portfolio companies. An example of this is greenhouse gas reduction targets that we have set under the Science Based Targets initiative in line with the 1.5°C scenario and our commitment to net-zero GHG emissions by 2040. We have a broad presence in the unlisted market through our local and specialised teams. Our investment strategies cover real estate and infrastructure assets, natural capital and minority and majority investments in portfolio companies. We also provide wealth management solutions. Altogether, CapMan employs around 200 professionals in Helsinki, Jyväskylä, Stockholm, Copenhagen, Oslo, London and Luxembourg. We are listed on Nasdaq Helsinki since 2001. www.capman.com

Categories: News

Tags:

Ardian finalizes the sale of its iconic Parisian Renaissance building, located in the heart of the Golden Triangle

Ardian

Ardian, a world-leading private investment firm, announces the sale of the Renaissance building, one of its iconic real estate assets, located at 26bis – 32 rue François 1er, in the Paris Golden Triangle.

Ardian had acquired this historic complex, the former headquarters of the Europe 1 radio station, in May 2018 through Ardian Real Estate European Fund I. Ardian led a major restructuring project to reposition it as a unique, modern, and exceptional mixed-use building (for both office and retail), meeting the highest market standards.

Today, Renaissance is home to international law firm A&O Shearman, which occupies high-end office space, as well as prestigious names such as world-renowned art gallery Hauser & Wirth, Japanese fashion house Issey Miyake and luxury car manufacturer Jaguar Land Rover.

“Renaissance embodies a unique product which is the fruit of a project management effort of rare complexity and exemplary execution. The inimitability of this project, both in terms of its location and the quality of its execution, makes it a benchmark in the market. It is precisely this uniqueness that gives Renaissance its remarkable liquidity, even in a core market environment where there are not currently many transactions of this scale.” Sébastien Bégué, Head of Real Estate Investment Management & Managing Director, Ardian

“The sale of Renaissance, in a European market now showing signs of recovery, is a perfect illustration of Ardian’s ability to anticipate investor expectations and enhance the value of exceptional assets. This success testifies to the unique expertise of our teams in repositioning emblematic buildings and confirms the renewed appetite of long-term investors for high-quality products.” Stéphanie Bensimon, Member of the Executive Committee, Member of the Board of Ardian France & Head of Real Estate, Ardian

ABOUT ARDIAN

Ardian is a world-leading private investment firm, managing or advising $180bn of assets on behalf of more than 1,850 clients globally. Our broad expertise, spanning Private Equity, Real Assets and Credit, enables us to offer a wide range of investment opportunities and respond flexibly to our clients’ differing needs. Through Ardian Customized Solutions we create bespoke portfolios that allow institutional clients to specify the precise mix of assets they require and to gain access to funds managed by leading third-party sponsors. Private Wealth Solutions offers dedicated services and access solutions for private banks, family offices and private institutional investors worldwide. Ardian’s main shareholding group is its employees and we place great emphasis on developing its people and fostering a collaborative culture based on collective intelligence. Our 1,050+ employees, spread across 19 offices in Europe, the Americas, Asia and Middle East are strongly committed to the principles of Responsible Investment and are determined to make finance a force for good in society. Our goal is to deliver excellent investment performance combined with high ethical standards and social responsibility.
At Ardian we invest all of ourselves in building companies that last.

ardian.com

Media Contacts

Ardian

HEADLAND

ardian@headlandconsultancy.com 

Categories: News

Tags:

Adelis exits its investment in Europa Biosite

Adelis Equity
Report this content

Adelis Equity Partners Fund II (“Adelis”) has divested its majority stake in Europa Biosite, a specialist distributor of Life Science research reagents to EQT Healthcare Growth

Following the acquisition by Adelis in 2021, Europa Biosite has executed on a successful international buy and build strategy acquiring 5 companies in 4 years. By doing so the Company has established a position as the leading specialist distributor in its field – offering innovative products to thousands of Life Science researchers across the continent. In parallel, significant investments have been made into digital tools and marketing that enable a differentiated supplier value proposition and fuel new supplier acquisition and organic growth.

“We are very proud of the part we have played in building a unique European business that supports life science researchers in reaching their goals – ultimately helping to understand and cure disease. On behalf of Adelis, we would like to thank management and all employees, as well as our minority partners and board colleagues for their strong efforts these past years” say Lene Stern and Rasmus Molander. Sune Schmølker, CEO of Europa Biosite says: “We are uniquely positioned to take part in the continued growth of the Life Science reagent market after the significant investments made into building the Group. I am very grateful for the support we have received from Adelis and the board of directors over these past years. I am looking forward to working with the new owners to continue the development of our business”.

The parties have agreed not to disclose the purchase price. The transaction is subject to customary clearance from competition authorities.

Adelis was advised by Houlihan Lokey and White & Case on the transaction.

For further information:

Lucia Morris, Adelis Equity Partners, +46 76 103 12 92, lucia.morris@adelisequity.com

Sune Schmølker, Europa Biosite, sune.schmolker@europabiosite.com

About Europa Biosite

Europa Biosite is a specialist distributor of Life Science research reagents. Carrying a portfolio of over 10 million SKUs, it supports thousands of researchers across Europe and North America in reaching their research objectives. The company has 180 employees covering 17 countries, the majority of whom are scientifically trained and therefore able to provide expert technical support to customers. Under Adelis’ ownership the company has completed 5 acquisitions – creating a truly pan-European commercial footprint and adding further innovative products to the portfolio. For further information, please visit www.europabiosite.com.

About Adelis Equity Partners

Adelis is a growth partner for well-positioned companies in the Nordics and DACH region. Adelis partners with management and/or owners to build businesses in growth segments and with strong market positions. Since raising its first fund in 2013, Adelis has been one of the most active investors in the Nordic middle-market, making 47 platform investments and more than 270 add-on acquisitions. Adelis today manages approximately €4.5 billion in capital. For more information, please visit www.adelisequity.com.

Categories: News